Sunday, February 5, 2023
ADVT 
Health

COVID-19 recovery can take a few weeks even for young adults

Darpan News Desk The Canadian Press, 24 Jul, 2020 10:17 PM
  • COVID-19 recovery can take a few weeks even for young adults

Recovering from even mild coronavirus infections can take at least two to three weeks, according to U.S. research published Friday.

Lingering symptoms can even affect otherwise healthy young adults. Among those aged 18 to 34 with no chronic illness, 1 in 5 were still experiencing COVID-19 symptoms after two to three weeks, the study found.

Cough, fatigue and body aches were among the most common persistent symptoms.

Most previous research on long-lasting COVID-19 symptoms has focused on sicker hospitalized adults. Only 7% of patients in the new study needed hospital treatment.

The study was led by researchers at the Centers for Disease Control and Prevention. They did phone surveys of 274 patients in several states who tested positive for the virus between the end of March and June 4. Patients were queried two to three weeks after those tests.

About one-third of middle-aged adults had not fully recovered, and for those 50 and older, the rate was almost half.

Patients with chronic illness, especially obesity, were more likely to have lingering symptoms.

The results are somewhat surprising, since with flu and many other viral infections, most patients recover completely within two weeks, said Dr. Wesley Self of Vanderbilt University. He leads a network of 14 medical centres that collaborated with the CDC on the study.

Some of the current U.S. spikes in infections are thought to be driven by young adults gathering in bars and other places. Self said the study results should underscore that they “should take social distancing very seriously.”

Although COVID-19 has disproportionately affected Blacks and Hispanics, they were not more likely than others in this study to face long recoveries.

MORE Health ARTICLES

WATCH: Your help needed, A Mother's Plea to Help Baby Aryan Fight SMA #donate #support

WATCH: Your help needed, A Mother's Plea to Help Baby Aryan Fight SMA #donate #support

DO WATCH & PLEASE SHARE AS MUCH AS POSSIBLE! Baby Aryan's parents urge the community to help as the baby was diagnosed with TYPE 1 SPINAL MUSCULAR ATROPHY (SMA). There is a treatment available called ZOLGENSMA which is the most expensive drug in the world at this time it costs 2.1 million dollars USD (2.8 Million CAD).

WATCH: Your help needed, A Mother's Plea to Help Baby Aryan Fight SMA #donate #support

FDA tells doctors to discuss overdose antidote with patients

FDA tells doctors to discuss overdose antidote with patients

Doctors who prescribe opioid painkillers should tell their patients about a potentially life-saving medication that can reverse drug overdoses, according to new federal guidelines issued Thursday.

FDA tells doctors to discuss overdose antidote with patients

Virus antibodies fade fast but not necessarily protection

Virus antibodies fade fast but not necessarily protection

New research suggests that antibodies the immune system makes to fight the new coronavirus may only last a few months in people with mild illness, but that doesn’t mean protection also is gone or that it won’t be possible to develop an effective vaccine.

Virus antibodies fade fast but not necessarily protection

FDA calls for removal of fruity, disposable Puff Bar vapes

FDA calls for removal of fruity, disposable Puff Bar vapes

U.S. health officials are cracking down on a brand of fruity disposable e-cigarettes that is popular with teenagers, saying the company never received permission to sell them in the U.S.

FDA calls for removal of fruity, disposable Puff Bar vapes

Study links good health-care to COVID death rate

Study links good health-care to COVID death rate

Heart researchers say there's a surprising reason Canada has seen higher COVID-19 deaths than many countries with fewer health-care resources — more Canadians live longer with chronic disease, putting them at greater risk of dying from COVID-19.

Study links good health-care to COVID death rate

Fatty liver disease a growing public health concern in Canada: study

Fatty liver disease a growing public health concern in Canada: study

Doctors are warning that soaring rates of a common, but often undetected, liver disease could impose an enormous burden on Canadian health care over the next decade if there isn't more public awareness.

Fatty liver disease a growing public health concern in Canada: study

PrevNext